Collectively, our data show that TRIM32 is required for cell growth in both normal and tumorous glycolytic tissues, thus providing a novel molecular explanation for the upregulation of TRIM32 in multiple types of cancer cells. The gene discussed is TRIM32; the disease is cancer.